Archive for November, 2009

Cutaneous manifestations of diabetes

Wednesday, November 25th, 2009
indian J Dermatol Venereol Leprol. 2003;69:105

Cutaneous manifestation of diabetes mellitus.

Mahajan S, et al

One hundred consecutive diabetes mellitus patients attending the diabetic clinic of the hospital constituted the study group. One hundred age and sex matched non-diabetics were taken as controls. The majority, 63%, belonged to the 41-60 years age group and 98% had non-insulin dependent diabetes. Among the study group, 64% had one or more cutaneous manifestations as compared to 22% in the controls.  Infections comprised the largest group affecting 35 of the 64 cases. snip….Likewise syndromes of insulin resistance were seen in 4 patients of whom 3 had aconthosis nigricans and one had congenital lipodystrophy. Furthermore, 9 patients had dermatoses known to be associated with an increased incidence of diabetes; vitiligo in 4, acquired perforating dermatoses in 3, and lichen planus in 2. Four patients had dermatoses known to be associated with diabetes: psoriasis in 3 and diffuse alopecia in one. Three had adverse drug reactions to anti-diabetic therapy.

Dr Proctor adds: We have found hair loss in diabetes in experimental animals

 

Hair loss blogs

Tuesday, November 17th, 2009

Hair Loss Blog Hair Loss Blog blog Hair Loss Blog Hair regrowth Blog blog blog

Estrogen treatment of hair loss

Wednesday, November 11th, 2009

local estrogen application in male pattern hair loss

[Article in German]

Orfanos CE, Wüstner H.

In 30 male patients aged 17-37 with definite androgenetic (”male pattern”) alopecia (”hair loss”) the total urinary estrogen level was estimated before and after topical treatment: In 18 patients estrogen in a alcoholic vehicle was daily applied on the scalp skin; whereas 12 patients served as controls. Before treatment the average estrogen level of all patients with AA was 23.3 mum/24 hrs (individual data ranged from 9.4-45.6 mum/24 hrs) and was thus slightly elevated but still within the normal range. 3 and 6 months after treatment no significant differences of the urinary estrogen level were found between the controlled patients of the two groups and, similarly, no clinical side-effects of the estrogen application (gynecomasty etc.) were recorded. It seems, on the basis of this study, that a long-term topical <a href=”http://www.drproctor.com”>treatment of hair loss</a> with estrogen does not involve considerable risks regarding side-effects on male adults, in contrast to children and youngsters. snip….

Edited for blog